Search details
1.
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
BMC Cancer
; 22(1): 137, 2022 Feb 03.
Article
in English
| MEDLINE | ID: mdl-35114947
2.
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.
Blood
; 132(22): 2389-2400, 2018 11 29.
Article
in English
| MEDLINE | ID: mdl-30213873
3.
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.
Haematologica
; 104(12): 2443-2455, 2019 12.
Article
in English
| MEDLINE | ID: mdl-30975914
4.
Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.
Ann Hematol
; 98(2): 423-435, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30368590
5.
Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11.
Hum Mutat
; 39(4): 515-526, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29280214
6.
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.
Blood
; 128(12): 1609-13, 2016 09 22.
Article
in English
| MEDLINE | ID: mdl-27480113
7.
TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.
Tumour Biol
; 36(5): 3371-80, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25527155
8.
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Haematologica
; 100(3): 370-6, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25480502
9.
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.
Am J Hematol
; 90(5): 417-21, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25645263
10.
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia.
Blood
; 119(9): 2110-3, 2012 Mar 01.
Article
in English
| MEDLINE | ID: mdl-22234685
11.
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
Haematologica
; 98(7): 1124-31, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23585524
12.
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab.
Eur J Haematol
; 90(6): 479-85, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23506191
13.
TP53 aberrations in chronic lymphocytic leukemia.
Adv Exp Med Biol
; 792: 109-31, 2013.
Article
in English
| MEDLINE | ID: mdl-24014294
14.
Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.
Br J Haematol
; 178(6): 979-982, 2017 09.
Article
in English
| MEDLINE | ID: mdl-27470445
15.
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Blood
; 114(26): 5307-14, 2009 Dec 17.
Article
in English
| MEDLINE | ID: mdl-19850740
16.
ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.
Haematologica
; 101(9): e369-73, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27479817
17.
Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion.
Leuk Res
; 111: 106684, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34438120
18.
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation.
Biol Chem
; 391(2-3): 197-205, 2010.
Article
in English
| MEDLINE | ID: mdl-20128691
19.
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.
Cancer Treat Rev
; 88: 102026, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32592909
20.
PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.
Leuk Res
; 89: 106288, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31924585